HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 286/5/G863    most recent 00482.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (20) Citing Articles via Google Scholar Google Scholar Articles by MacNaughton, W. K. Articles by Sharkey, K. A. Search for Related Content PubMed PubMed Citation Articles by MacNaughton, W. K. Articles by Sharkey, K. A.

NEUROREGULATION AND MOTILITY

Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves

¹Mucosal Inflammation, ²Gastrointestinal, and ³Neuroscience Research Groups, Department of Physiology and Biophysics, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; and ⁴Departments of Anesthesiology and Physiology and Biophysics, University of Washington, Seattle, Washington 98195

Submitted 17 November 2003 ; accepted in final form 15 December 2003

We investigated the distribution and function of cannabinoid (CB)₁ receptors in the submucosal plexus of the guinea pig ileum. CB₁ receptors were found on both types of submucosal secretomotor neurons, colocalizing with VIP and neuropeptide Y (NPY), the noncholinergic and cholinergic secretomotor neurons, respectively. CB₁ receptors colocalized with transient receptor potential vanilloid-1 receptors on paravascular nerves and fibers in the submucosal plexus. In the submucosal ganglia, these nerves were preferentially localized at the periphery of the ganglia. In denervated ileal segments, CB₁ receptor immunoreactivity in submucosal neurons was not modified, but paravascular and intraganglionic fiber staining was absent. Short-circuit current (I_sc) was measured as an indicator of net electrogenic ion transport in Ussing chambers. In the ion-transport studies, I_sc responses to capsaicin, which activates extrinsic primary afferents, and to electrical field stimulation (EFS) were reduced by pretreatment with the muscarinic antagonist atropine, abolished by tetrodotoxin, but were unaffected by VIP receptor desensitization, hexamethonium, -amino-3-hydroxy-5-methlisoxazole-4-proprionic acid, or N-methyl-D-aspartate glutamate receptor antagonists. The responses to capsaicin and EFS were reduced by 47 ± 12 and 30 ± 14%, respectively, by the CB₁ receptor agonist WIN 55,212–2. This inhibitory effect was blocked by the CB₁ receptor antagonist, SR 141716A. I_sc responses to forskolin or carbachol, which act directly on the epithelium, were not affected by WIN 55,212–2. The inhibitory effect of WIN 55,212–2 on EFS-evoked secretion was not observed in extrinsically denervated segments of ileum. Taken together, these data show cannabinoids act at CB₁ receptors on extrinsic primary afferent nerves, inhibiting the release of transmitters that act on cholinergic secretomotor pathways.

submucosal plexus; vasoactive intestinal peptide; neuropeptide Y; transient receptor potential vanilloid-1 receptor

This article has been cited by other articles:

				M. Brusberg, S. Arvidsson, D. Kang, H. Larsson, E. Lindstrom, and V. Martinez CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents J. Neurosci., February 4, 2009; 29(5): 1554 - 1564. [Abstract] [Full Text] [PDF]

				D. Wang, H. Wang, W. Ning, M. G. Backlund, S. K. Dey, and R. N. DuBois Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth Cancer Res., August 1, 2008; 68(15): 6468 - 6476. [Abstract] [Full Text] [PDF]

				A A Izzo and M Camilleri Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects Gut, August 1, 2008; 57(8): 1140 - 1155. [Abstract] [Full Text] [PDF]

				J. P. Prestifilippo, J. Fernandez-Solari, C. de la Cal, M. Iribarne, A. M. Suburo, V. Rettori, S. M. McCann, and J. C. Elverdin Inhibition of Salivary Secretion by Activation of Cannabinoid Receptors Experimental Biology and Medicine, September 1, 2006; 231(8): 1421 - 1429. [Abstract] [Full Text] [PDF]

				H. Hassani, G. Lucas, B. Rozell, and P. Ernfors Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G550 - G556. [Abstract] [Full Text] [PDF]

				P. Dinis, A. Charrua, A. Avelino, M. Yaqoob, S. Bevan, I. Nagy, and F. Cruz Anandamide-Evoked Activation of Vanilloid Receptor 1 Contributes to the Development of Bladder Hyperreflexia and Nociceptive Transmission to Spinal Dorsal Horn Neurons in Cystitis J. Neurosci., December 15, 2004; 24(50): 11253 - 11263. [Abstract] [Full Text] [PDF]